CVS Strikes $22M Deal With Feds In Fla. Oxycodone Probe

Law360, Miami (May 13, 2015, 7:32 PM EDT) -- CVS Health Corp. has entered into a $22 million agreement to resolve allegations relating to two of its stores in Sanford, Florida, which lost their controlled substances licenses for filing suspicious orders for the painkiller oxycodone two years ago.

The agreement, announced by the U.S. Attorney's Office for the Middle District of Florida and disclosed in a CVS filing with the U.S. Securities and Exchange Commission on Wednesday, resolves all civil matters between the company and the U.S. Drug Enforcement Administration and the state of Florida....
To view the full article, register now.